Pub Date : 2025-07-01Epub Date: 2025-05-29DOI: 10.1097/EDE.0000000000001870
{"title":"Liacine Bouaoun, Winner of the 2025 Rothman Prize.","authors":"","doi":"10.1097/EDE.0000000000001870","DOIUrl":"https://doi.org/10.1097/EDE.0000000000001870","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":"36 4","pages":"439"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-05-29DOI: 10.1097/EDE.0000000000001860
Nicholas T Williams, Anton Hung, Kara E Rudolph
{"title":"Re: Don't Let Your Analysis Go to Seed: On the Impact of Random Seed on Machine Learning-based Causal Inference.","authors":"Nicholas T Williams, Anton Hung, Kara E Rudolph","doi":"10.1097/EDE.0000000000001860","DOIUrl":"10.1097/EDE.0000000000001860","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":"36 4","pages":"e12-e13"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-02-25DOI: 10.1097/EDE.0000000000001842
Charles F Manski
{"title":"Erratum: Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose.","authors":"Charles F Manski","doi":"10.1097/EDE.0000000000001842","DOIUrl":"10.1097/EDE.0000000000001842","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"e18"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143515116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-03-31DOI: 10.1097/EDE.0000000000001855
Dae-Hee Han, Adam M Leventhal, Andrew C Stokes, Janet E Audrain-McGovern, Sandrah P Eckel, Jessica Liu, Alyssa F Harlow
Background: Prior studies examining the association of cannabis use with nicotine abstinence did not distinguish between individuals co-using nicotine and cannabis versus those who switched from nicotine to exclusive cannabis use; these may have different effects on nicotine abstinence. We examined associations of cannabis use uptake with subsequent nicotine abstinence approximately 1 year later among adults using cigarettes and/or e-cigarettes.
Methods: Using six waves of the Population Assessment of Tobacco and Health Study (2013-2021), we assessed transitions from exclusive nicotine use prebaseline (time t ) to (1) exclusive cannabis use, (2) nicotine-cannabis co-use, (3) nonuse of both nicotine and cannabis, and (4) continued exclusive nicotine use at baseline ( t + 1) as exposure variables. Analyses examined associations with nicotine abstinence (from both cigarettes and e-cigarettes) at 1-year follow-up ( t + 2).
Results: Among 8382 adults (19,618 observations) reporting exclusive nicotine use prebaseline, 1% transitioned to exclusive cannabis use, 9% to nicotine-cannabis co-use, and 9% to nonuse of both drugs; 81% were still using nicotine exclusively at baseline. Transition to nicotine-cannabis co-use (6%) versus exclusive nicotine use (10%) was inversely associated with nicotine abstinence at follow-up (adjusted relative risk [aRR] = 0.68; 95% confidence interval [CI] = 0.55, 0.83). Transition to exclusive cannabis use (72%) was positively associated with nicotine abstinence compared with continued exclusive nicotine use (10%; aRR = 4.66; 95% CI = 3.83, 5.67) and with similar nicotine abstinence at follow-up (72%) compared with nonuse of both drugs (65%; aRR=0.98; 95% CI = 0.81, 1.18).
Conclusion: Co-use of nicotine and cannabis was associated with lower nicotine abstinence. Switching to exclusive cannabis use was associated with similar or greater nicotine abstinence.
{"title":"Nicotine-Cannabis Transitions and Nicotine Abstinence Among United States Adults.","authors":"Dae-Hee Han, Adam M Leventhal, Andrew C Stokes, Janet E Audrain-McGovern, Sandrah P Eckel, Jessica Liu, Alyssa F Harlow","doi":"10.1097/EDE.0000000000001855","DOIUrl":"10.1097/EDE.0000000000001855","url":null,"abstract":"<p><strong>Background: </strong>Prior studies examining the association of cannabis use with nicotine abstinence did not distinguish between individuals co-using nicotine and cannabis versus those who switched from nicotine to exclusive cannabis use; these may have different effects on nicotine abstinence. We examined associations of cannabis use uptake with subsequent nicotine abstinence approximately 1 year later among adults using cigarettes and/or e-cigarettes.</p><p><strong>Methods: </strong>Using six waves of the Population Assessment of Tobacco and Health Study (2013-2021), we assessed transitions from exclusive nicotine use prebaseline (time t ) to (1) exclusive cannabis use, (2) nicotine-cannabis co-use, (3) nonuse of both nicotine and cannabis, and (4) continued exclusive nicotine use at baseline ( t + 1) as exposure variables. Analyses examined associations with nicotine abstinence (from both cigarettes and e-cigarettes) at 1-year follow-up ( t + 2).</p><p><strong>Results: </strong>Among 8382 adults (19,618 observations) reporting exclusive nicotine use prebaseline, 1% transitioned to exclusive cannabis use, 9% to nicotine-cannabis co-use, and 9% to nonuse of both drugs; 81% were still using nicotine exclusively at baseline. Transition to nicotine-cannabis co-use (6%) versus exclusive nicotine use (10%) was inversely associated with nicotine abstinence at follow-up (adjusted relative risk [aRR] = 0.68; 95% confidence interval [CI] = 0.55, 0.83). Transition to exclusive cannabis use (72%) was positively associated with nicotine abstinence compared with continued exclusive nicotine use (10%; aRR = 4.66; 95% CI = 3.83, 5.67) and with similar nicotine abstinence at follow-up (72%) compared with nonuse of both drugs (65%; aRR=0.98; 95% CI = 0.81, 1.18).</p><p><strong>Conclusion: </strong>Co-use of nicotine and cannabis was associated with lower nicotine abstinence. Switching to exclusive cannabis use was associated with similar or greater nicotine abstinence.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"551-559"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-04-09DOI: 10.1097/EDE.0000000000001854
Elena Milkovska, Bram Wouterse, Jawa Issa, Pieter van Baal
Background: The coronavirus disease 2019 (COVID-19) pandemic caused substantial health losses but not much is known about how these are distributed across the population. We aimed to estimate the distribution of years of life lost (YLL) due to COVID-19 and investigate its variation across the Dutch population, taking into account preexisting differences in health.
Methods: We used linked administrative data covering the entire 50+ Dutch population over 2012-2018 (n = 6,102,334) to estimate counterfactual individual-level life expectancy for those who died from COVID-19 in 2020 and 2021. We estimated survival models and used Cox-LASSO and Cox-Elastic Net to perform variable selection among the large set of potential predictors in our data. Using individual-level life expectancy predictions, we generated the distribution of YLL due to COVID-19 for the entire 50+ population by age and income.
Results: On average, we estimate that individuals who died of COVID-19 had a counterfactual life expectancy about 28% lower than that of the rest of the population. Within this average, there was substantial heterogeneity, with 20% of all individuals who died of COVID-19 having an estimated life expectancy exceeding that of the age-specific population average. Both the richest and poorest COVID-19 decedents lost the same average number of YLL, which were similarly dispersed.
Conclusion: Accounting for preexisting health problems is crucial when estimating YLL due to COVID-19. While average life expectancy among COVID-19 decedents was substantially lower than for the rest of the population, the popular notion that only the frail died from COVID-19 is not true.
{"title":"Quantifying the Health Burden of COVID-19 Using Individual Estimates of Years of Life Lost Based on Population-wide Administrative Level Data.","authors":"Elena Milkovska, Bram Wouterse, Jawa Issa, Pieter van Baal","doi":"10.1097/EDE.0000000000001854","DOIUrl":"10.1097/EDE.0000000000001854","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic caused substantial health losses but not much is known about how these are distributed across the population. We aimed to estimate the distribution of years of life lost (YLL) due to COVID-19 and investigate its variation across the Dutch population, taking into account preexisting differences in health.</p><p><strong>Methods: </strong>We used linked administrative data covering the entire 50+ Dutch population over 2012-2018 (n = 6,102,334) to estimate counterfactual individual-level life expectancy for those who died from COVID-19 in 2020 and 2021. We estimated survival models and used Cox-LASSO and Cox-Elastic Net to perform variable selection among the large set of potential predictors in our data. Using individual-level life expectancy predictions, we generated the distribution of YLL due to COVID-19 for the entire 50+ population by age and income.</p><p><strong>Results: </strong>On average, we estimate that individuals who died of COVID-19 had a counterfactual life expectancy about 28% lower than that of the rest of the population. Within this average, there was substantial heterogeneity, with 20% of all individuals who died of COVID-19 having an estimated life expectancy exceeding that of the age-specific population average. Both the richest and poorest COVID-19 decedents lost the same average number of YLL, which were similarly dispersed.</p><p><strong>Conclusion: </strong>Accounting for preexisting health problems is crucial when estimating YLL due to COVID-19. While average life expectancy among COVID-19 decedents was substantially lower than for the rest of the population, the popular notion that only the frail died from COVID-19 is not true.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"520-530"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-05-29DOI: 10.1097/EDE.0000000000001872
Bronner P Gonçalves, Etsuji Suzuki
{"title":"Erratum: Effect Modification in Settings with \"Truncation by Death\".","authors":"Bronner P Gonçalves, Etsuji Suzuki","doi":"10.1097/EDE.0000000000001872","DOIUrl":"10.1097/EDE.0000000000001872","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"e20"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144156795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-03-24DOI: 10.1097/EDE.0000000000001852
Jessie K Edwards, Tiffany L Breger, Stephen R Cole, Paul N Zivich, Bonnie E Shook-Sa, Leah M Sadinski, Daniel Westreich, Andrew Edmonds, Catalina Ramirez, Igho Ofotokun, Seble G Kassaye, Todd T Brown, Deborah Konkle-Parker, Valentina Stosor, Robert Bolan, Sarah Krier, Deborah L Jones, Gypsyamber D'Souza, Mardge Cohen, Phyllis C Tien, Tonya Taylor, Kathryn Anastos, M Bradley Drummond, Michelle Floris-Moore
Background: Epidemiologists frequently employ right censoring to handle missing outcome, covariate, or exposure data incurred when participants have large gaps between study visits or stop attending study visits entirely. But, if participants who are censored are more or less likely to experience outcomes of interest than those not censored, such censoring could introduce bias in estimated measures.
Methods: We examined how censoring after two consecutive missed visits may affect mortality results from the Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS). MACS and WIHS provide linkages to vital statistics registries, such that mortality data were available for all participants, regardless of whether they attended study visits.
Results: In a gold standard analysis that did not censor after two consecutive missed visits, 10-year mortality was 23% (95% CI: 22, 24) in MACS and 21% (95% CI: 20, 23) in WIHS. Estimated mortality was modestly reduced by 0%-5% across subgroups when censoring at missed visits. Applying inverse probability of censoring weights partially removed this attenuation.
Conclusions: While mortality was slightly elevated after two consecutive missed visits in MACS and WIHS, censoring at two consecutive missed visits did not substantially alter estimated mortality, particularly after applying inverse probability of censoring weights.
{"title":"Right Censoring and Mortality in the Multicenter AIDS Cohort Study and Women's Interagency HIV Study.","authors":"Jessie K Edwards, Tiffany L Breger, Stephen R Cole, Paul N Zivich, Bonnie E Shook-Sa, Leah M Sadinski, Daniel Westreich, Andrew Edmonds, Catalina Ramirez, Igho Ofotokun, Seble G Kassaye, Todd T Brown, Deborah Konkle-Parker, Valentina Stosor, Robert Bolan, Sarah Krier, Deborah L Jones, Gypsyamber D'Souza, Mardge Cohen, Phyllis C Tien, Tonya Taylor, Kathryn Anastos, M Bradley Drummond, Michelle Floris-Moore","doi":"10.1097/EDE.0000000000001852","DOIUrl":"10.1097/EDE.0000000000001852","url":null,"abstract":"<p><strong>Background: </strong>Epidemiologists frequently employ right censoring to handle missing outcome, covariate, or exposure data incurred when participants have large gaps between study visits or stop attending study visits entirely. But, if participants who are censored are more or less likely to experience outcomes of interest than those not censored, such censoring could introduce bias in estimated measures.</p><p><strong>Methods: </strong>We examined how censoring after two consecutive missed visits may affect mortality results from the Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS). MACS and WIHS provide linkages to vital statistics registries, such that mortality data were available for all participants, regardless of whether they attended study visits.</p><p><strong>Results: </strong>In a gold standard analysis that did not censor after two consecutive missed visits, 10-year mortality was 23% (95% CI: 22, 24) in MACS and 21% (95% CI: 20, 23) in WIHS. Estimated mortality was modestly reduced by 0%-5% across subgroups when censoring at missed visits. Applying inverse probability of censoring weights partially removed this attenuation.</p><p><strong>Conclusions: </strong>While mortality was slightly elevated after two consecutive missed visits in MACS and WIHS, censoring at two consecutive missed visits did not substantially alter estimated mortality, particularly after applying inverse probability of censoring weights.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"511-519"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12122228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-04-01DOI: 10.1097/EDE.0000000000001866
S Ghazaleh Dashti, Katherine J Lee, Julie A Simpson, John B Carlin, Margarita Moreno-Betancur
The interventional effects approach to causal mediation analysis is increasingly common in epidemiologic research given its potential to address policy-relevant questions about hypothetical mediator interventions. Multiple imputation is widely used for handling multivariable missing data in epidemiologic studies. However, guidance is lacking on best practices for using multiple imputation when estimating interventional mediation effects, specifically regarding the role of missingness mechanism in the performance of the method, how to appropriately specify the multiple imputation model when g-computation is used for effect estimation, and appropriate variance estimation. To address this gap, we conducted simulations based on the Victorian Adolescent Health Cohort Study. We considered seven missingness mechanisms, involving varying assumptions regarding the influence of an intermediate confounder, a mediator, and/or the outcome on missingness in key variables. We compared the performance of complete case analysis, six multiple imputation approaches by fully conditional specification, differing in how the imputation model was tailored, and a "substantive model compatible" multiple imputation-fully conditional specification approach. We evaluated MIBoot (multiple imputation, then bootstrap) and BootMI (bootstrap, then multiple imputation) approaches for variance estimation. All multiple imputation approaches, apart from those clearly diverging from best practice, yielded approximately unbiased estimates when none of the intermediate confounder, mediator, and outcome variables influenced missingness in any of these variables and nonnegligible bias otherwise. We observed the largest bias for interventional effects when each of the intermediate confounders, mediators, and outcomes influenced their own missingness. BootMI returned variance estimates with a smaller bias than MIBoot.
因果中介分析的干预效应方法在流行病学研究中越来越普遍,因为它有可能解决关于假设中介干预的政策相关问题。在流行病学研究中,多重插值法被广泛用于处理多变量缺失数据。然而,在评估干预中介效应时使用多重归算的最佳实践方面缺乏指导,特别是缺失机制在方法性能中的作用,如何在使用g计算进行效果估计时适当指定多重归算模型,以及适当的方差估计。为了解决这一差距,我们进行了基于维多利亚青少年健康队列研究的模拟。我们考虑了7种缺失机制,包括关于中间混杂因素、中介因素和/或结果对关键变量缺失的影响的不同假设。我们比较了完整案例分析、六种基于完全条件规范的多重归算方法(在归算模型的定制方式上有所不同)和一种“实体模型兼容”的多重归算-完全条件规范方法的性能。我们评估了用于方差估计的MIBoot (multiple imputation, then bootstrap)和BootMI (bootstrap, then multiple imputation)方法。除了那些明显偏离最佳实践的方法外,当中间混杂因素、中介因素和结果变量都不影响任何这些变量的缺失和不可忽略的偏差时,所有的多重归算方法都产生了近似无偏估计。我们观察到,当每个中间混杂因素、中介因素和结果影响它们自己的缺失时,干预效应的偏差最大。BootMI返回的方差估计偏差小于MIBoot。
{"title":"Handling Multivariable Missing Data in Causal Mediation Analysis Estimating Interventional Effects.","authors":"S Ghazaleh Dashti, Katherine J Lee, Julie A Simpson, John B Carlin, Margarita Moreno-Betancur","doi":"10.1097/EDE.0000000000001866","DOIUrl":"10.1097/EDE.0000000000001866","url":null,"abstract":"<p><p>The interventional effects approach to causal mediation analysis is increasingly common in epidemiologic research given its potential to address policy-relevant questions about hypothetical mediator interventions. Multiple imputation is widely used for handling multivariable missing data in epidemiologic studies. However, guidance is lacking on best practices for using multiple imputation when estimating interventional mediation effects, specifically regarding the role of missingness mechanism in the performance of the method, how to appropriately specify the multiple imputation model when g-computation is used for effect estimation, and appropriate variance estimation. To address this gap, we conducted simulations based on the Victorian Adolescent Health Cohort Study. We considered seven missingness mechanisms, involving varying assumptions regarding the influence of an intermediate confounder, a mediator, and/or the outcome on missingness in key variables. We compared the performance of complete case analysis, six multiple imputation approaches by fully conditional specification, differing in how the imputation model was tailored, and a \"substantive model compatible\" multiple imputation-fully conditional specification approach. We evaluated MIBoot (multiple imputation, then bootstrap) and BootMI (bootstrap, then multiple imputation) approaches for variance estimation. All multiple imputation approaches, apart from those clearly diverging from best practice, yielded approximately unbiased estimates when none of the intermediate confounder, mediator, and outcome variables influenced missingness in any of these variables and nonnegligible bias otherwise. We observed the largest bias for interventional effects when each of the intermediate confounders, mediators, and outcomes influenced their own missingness. BootMI returned variance estimates with a smaller bias than MIBoot.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"487-499"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-04-04DOI: 10.1097/EDE.0000000000001857
Juha Luukkonen, Elina Einiö, Lasse Tarkiainen, Pekka Martikainen, Hanna Remes
Background: Little is known about how alcohol policies experienced in adolescence are associated with later health. We assess whether the age of exposure to stricter alcohol policies is associated with later alcohol-attributable hospitalizations and mortality. We take advantage of an alcohol advertising ban and alcohol tax increases introduced in 1975-1977 with relatively stable alcohol policies before and after.
Methods: We used Finnish register data on birth cohorts 1950-1964 (1,175,878 individuals) to assess cohort-wise hazard ratios for the first incidence of alcohol-attributable hospitalization and mortality, and mortality due to external and other causes at ages 21-54 years.
Results: Men who were aged 19-25 at the time of the restrictive reform had similar risks for alcohol-attributable hospitalization and mortality to the reference group of those aged 18-legal drinking age-at the time of reform. For those underage at the time, hospitalization and mortality rates were incrementally smaller cohort by cohort. For example, men who were 17 at the time of the reform had lower hazard ratios of alcohol-attributable hospitalization: 0.91 (95% confidence interval: 0.87, 0.95) as did those who were 13 (0.85; 95% confidence interval: 0.81, 0.89). The findings were similar for external-cause mortality, and similar yet more uncertain for women. In contrast, mortality from other causes declined continuously from cohort to cohort.
Conclusions: Our findings are consistent with the hypothesis that stricter alcohol policies in adolescence reduce harmful alcohol consumption patterns extending into adulthood and manifesting as lower alcohol-related harm to health.
背景:青少年时期的酒精政策与后期健康之间的关系尚不清楚。我们评估暴露于更严格的酒精政策的年龄是否与后来因酒精引起的住院和死亡率有关。我们利用了1975-1977年禁酒和增加酒税的优势,前后的酒精政策相对稳定。方法:我们使用芬兰1950-1964年出生队列的登记数据(1,175,878人)来评估21-54岁人群中首次因酒精引起的住院和死亡率以及外部和其他原因导致的死亡率的队列风险比。结果:在限制性改革时年龄在19至25岁的男性与在改革时年龄在18岁(法定饮酒年龄)的参照组有相似的酒精导致的住院和死亡风险。对于当时的未成年人,住院率和死亡率逐群递减。例如,改革时17岁的男性因酒精住院的风险比较低:0.91 (95% CI 0.87;0.95), 13岁[0.85](95% CI 0.81;0.89)]。研究结果与外因死亡率相似,与女性相似,但更不确定。相比之下,其他原因的死亡率在队列间持续下降。结论:我们的研究结果与假设一致,即青春期更严格的酒精政策可以减少有害的酒精消费模式,并延伸到成年期,并表现为降低酒精对健康的危害。
{"title":"Alcohol Policy in Adolescence and Subsequent Alcohol-attributable Hospitalizations and Mortality at Ages 21-54 Years: A Register-based Cohort Study.","authors":"Juha Luukkonen, Elina Einiö, Lasse Tarkiainen, Pekka Martikainen, Hanna Remes","doi":"10.1097/EDE.0000000000001857","DOIUrl":"10.1097/EDE.0000000000001857","url":null,"abstract":"<p><strong>Background: </strong>Little is known about how alcohol policies experienced in adolescence are associated with later health. We assess whether the age of exposure to stricter alcohol policies is associated with later alcohol-attributable hospitalizations and mortality. We take advantage of an alcohol advertising ban and alcohol tax increases introduced in 1975-1977 with relatively stable alcohol policies before and after.</p><p><strong>Methods: </strong>We used Finnish register data on birth cohorts 1950-1964 (1,175,878 individuals) to assess cohort-wise hazard ratios for the first incidence of alcohol-attributable hospitalization and mortality, and mortality due to external and other causes at ages 21-54 years.</p><p><strong>Results: </strong>Men who were aged 19-25 at the time of the restrictive reform had similar risks for alcohol-attributable hospitalization and mortality to the reference group of those aged 18-legal drinking age-at the time of reform. For those underage at the time, hospitalization and mortality rates were incrementally smaller cohort by cohort. For example, men who were 17 at the time of the reform had lower hazard ratios of alcohol-attributable hospitalization: 0.91 (95% confidence interval: 0.87, 0.95) as did those who were 13 (0.85; 95% confidence interval: 0.81, 0.89). The findings were similar for external-cause mortality, and similar yet more uncertain for women. In contrast, mortality from other causes declined continuously from cohort to cohort.</p><p><strong>Conclusions: </strong>Our findings are consistent with the hypothesis that stricter alcohol policies in adolescence reduce harmful alcohol consumption patterns extending into adulthood and manifesting as lower alcohol-related harm to health.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"580-589"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143788096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-03-31DOI: 10.1097/EDE.0000000000001858
Stephen R Cole, Alexander Breskin, Bonnie E Shook-Sa, Paul N Zivich, Michael G Hudgens, Jessie K Edwards
{"title":"Five Facts About Influence Functions.","authors":"Stephen R Cole, Alexander Breskin, Bonnie E Shook-Sa, Paul N Zivich, Michael G Hudgens, Jessie K Edwards","doi":"10.1097/EDE.0000000000001858","DOIUrl":"10.1097/EDE.0000000000001858","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"467-472"},"PeriodicalIF":4.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}